Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)

Background: In people with overweight or obesity, long-term maintenance of weight loss is challenging. Subcutaneous (s.c.) semaglutide, a glucagon-like peptide-1 analogue, has shown clinically-relevant weight loss in a phase 2 trial in people with obesity. STEP 4 investigated the impact of continued...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Endocr Soc
Main Authors: Rubino, Domenica M, Abrahamsson, Niclas, Davies, Melanie, Hesse, Dan, Greenway, Frank L, Jensen, Camilla, Lingvay, Ildiko, Mosenzon, Ofri, Rosenstock, Julio, Rubio, Miguel A, Rudofsky, Gottfried, Tadayon, Sayeh, Wadden, Thomas A, Dicker, Dror
格式: Artigo
語言:Inglês
出版: Oxford University Press 2021
主題:
Adipose Tissue, Appetite, and Obesity
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089318/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.129
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍